Literature DB >> 14514036

Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells.

Ming Yang1, Angela E Donaldson, Yubao Jiang, Lorraine Iacovitti.   

Abstract

1. Our previous studies demonstrated that when neural stem cells (NSCs) of the C17.2 clonal line are transplanted into the intact or 6-hydroxydopamine (6-OHDA) lesioned rat striatum, in most, but not all grafts, cells spontaneously express the dopamine (DA) biosynthetic enzymes, tyrosine hydroxylase (TH), and aromatic L-amino acid decarboxylase (Yang, M., Stull, N. D., Snyder. E. Y., Berk, M. A., and Iacovitti, L. (2002). Exp. Neurol.). 2. These results suggested that there were certain conditions which were more conducive to the development of DA traits in NSCs and possibly other neurotransmitter phenotypes. 3. In the present study, we modified a number of variables in vitro (i.e. passage number, confluence) and/or in vivo (degree, type, and site of injury) before assessing the survival, migration. and differentiation of engrafted NSCs. 4. We found that low confluence cultures were comprised exclusively of flattened polygonal cells, which when transplanted, migrated widely in the brain but did not express TH. 5. In contrast, high confluence cultures contained both polygonal cells and an overlying bed of fusiform cells. 6. When these NSCs were maintained for 12-20 passages and then transplanted, virtually all engrafted cells in 65% of the grafts expressed TH but not markers of other neurotransmitter systems. 7. Importantly, all TH+ grafts were accompanied by significant physical damage to the brain while TH- grafts were not, suggesting that local injury-related factors were also important. 8. Of no apparent influence on TH expression, regardless of how cells were grown prior to implantation, was the site of transplantation (cortex or striatum) or the degree of chemical lesion (intact, partial or full). 9. We conclude that transplanted NSCs can express traits specifically associated with DA neurons but only when cells are grown under certain conditions in vitro and then transplanted in proximity to injury-induced factors present in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514036      PMCID: PMC1949421          DOI: 10.1023/a:1025017423102

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  32 in total

1.  Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes.

Authors:  J Wagner; P Akerud; D S Castro; P C Holm; J M Canals; E Y Snyder; T Perlmann; E Arenas
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

2.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

Authors:  S H Lee; N Lumelsky; L Studer; J M Auerbach; R D McKay
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

Review 3.  Cell replacement therapies for central nervous system disorders.

Authors:  A Björklund; O Lindvall
Journal:  Nat Neurosci       Date:  2000-06       Impact factor: 24.884

4.  Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity.

Authors:  H Kawasaki; K Mizuseki; S Nishikawa; S Kaneko; Y Kuwana; S Nakanishi; S I Nishikawa; Y Sasai
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

5.  Cholinergic expression by a neural stem cell line grafted to the adult medial septum/diagonal band complex.

Authors:  L C Doering; E Y Snyder
Journal:  J Neurosci Res       Date:  2000-09-15       Impact factor: 4.164

6.  Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts.

Authors:  M Emgård; J Karlsson; O Hansson; P Brundin
Journal:  Exp Neurol       Date:  1999-11       Impact factor: 5.330

7.  Macrophage cell-conditioned medium promotes cholinergic differentiation of undifferentiated progenitors and synergizes with nerve growth factor action in the developing basal forebrain.

Authors:  G M Jonakait; Y Wen; Y Wan; L Ni
Journal:  Exp Neurol       Date:  2000-01       Impact factor: 5.330

8.  Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.

Authors:  H Nishino; H Hida; N Takei; M Kumazaki; K Nakajima; H Baba
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

9.  Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats.

Authors:  L Studer; V Tabar; R D McKay
Journal:  Nat Neurosci       Date:  1998-08       Impact factor: 24.884

10.  Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors.

Authors:  J Yan; L Studer; R D McKay
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

View more
  17 in total

1.  A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo.

Authors:  Lorraine Iacovitti; Angela E Donaldson; Cheryl E Marshall; Sokreine Suon; Ming Yang
Journal:  Brain Res       Date:  2006-11-21       Impact factor: 3.252

2.  Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat.

Authors:  Dasa Cízková; Ján Rosocha; Ivo Vanický; Stanislava Jergová; Milan Cízek
Journal:  Cell Mol Neurobiol       Date:  2006-07-29       Impact factor: 5.046

Review 3.  Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.

Authors:  I Dela Peña; P R Sanberg; S Acosta; N Tajiri; S Z Lin; C V Borlongan
Journal:  J Neurosurg Sci       Date:  2014-05-20       Impact factor: 2.279

4.  Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats.

Authors:  Naoki Tajiri; Sandra A Acosta; Md Shahaduzzaman; Hiroto Ishikawa; Kazutaka Shinozuka; Mibel Pabon; Diana Hernandez-Ontiveros; Dae Won Kim; Christopher Metcalf; Meaghan Staples; Travis Dailey; Julie Vasconcellos; Giorgio Franyuti; Lisa Gould; Niketa Patel; Denise Cooper; Yuji Kaneko; Cesar V Borlongan; Paula C Bickford
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

5.  Transient differentiation of adult human bone marrow cells into neuron-like cells in culture: development of morphological and biochemical traits is mediated by different molecular mechanisms.

Authors:  Sokreine Suon; Hao Jin; Angela E Donaldson; E J Caterson; Rocky S Tuan; Geoffrey Deschennes; Cheryl Marshall; Lorraine Iacovitti
Journal:  Stem Cells Dev       Date:  2004-12       Impact factor: 3.272

6.  Studies on the differentiation of dopaminergic traits in human neural progenitor cells in vitro and in vivo.

Authors:  Ming Yang; Angela E Donaldson; Cheryl E Marshall; James Shen; Lorraine Iacovitti
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

7.  Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture.

Authors:  A E Donaldson; C E Marshall; Ming Yang; S Suon; Lorraine Iacovitti
Journal:  Mol Cell Neurosci       Date:  2005-09       Impact factor: 4.314

8.  Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson's disease: small animal positron emission tomography study with F-18 FP-CIT.

Authors:  Bok-Nam Park; Jang-Hee Kim; Kwanjae Lee; So Hyun Park; Young-Sil An
Journal:  Eur Radiol       Date:  2014-12-11       Impact factor: 5.315

9.  Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

Authors:  Feifei Wang; Takao Yasuhara; Tetsuro Shingo; Masahiro Kameda; Naoki Tajiri; Wen Ji Yuan; Akihiko Kondo; Tomohito Kadota; Tanefumi Baba; Judith Thomas Tayra; Yoichiro Kikuchi; Yasuyuki Miyoshi; Isao Date
Journal:  BMC Neurosci       Date:  2010-04-26       Impact factor: 3.288

10.  Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease.

Authors:  Kimberly B Bjugstad; Yang D Teng; D Eugene Redmond; John D Elsworth; Robert H Roth; Shannon K Cornelius; Evan Y Snyder; John R Sladek
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.